U.S. Marine and Shipping Stock News

If you are wondering whether Bloom Energy's share price still reflects fair value after its recent run, you are not alone. That is exactly what this article is built to unpack. The stock last closed at US$139.17, with returns of 14.2% over 7 days, 58.9% over 30 days, 41.0% year to date, and a very large gain over 1 year and 3 years. This naturally raises questions about growth expectations and risk. Recent news coverage around Bloom Energy has focused on its role in clean energy solutions...

Earlier this week, DocuSign announced new AI-powered eSignature features built on its Intelligent Agreement Management platform, using its Iris engine to simplify dense legal language for signers and automate document preparation tasks like agreement-type detection and field placement across the US, UK, and Australia. The launch directly targets long-standing friction points in contract workflows, signer confusion, preparation errors, and time-intensive setup, positioning DocuSign’s AI as...

Antero Midstream (AM) has kept its quarterly cash dividend at $0.225 per share, alongside fourth quarter share repurchases and new senior notes offerings that reshape how cash flows between the company and its investors. See our latest analysis for Antero Midstream. At a share price of US$17.84, Antero Midstream has seen a 7 day share price return of 2.94% while its 1 year total shareholder return of 15.25% and 5 year total shareholder return above 200% reflect gradually building momentum...

If you are wondering whether Rezolve AI's recent run makes the stock look cheap or stretched, this article walks through what the current price could imply about its value. The shares last closed at US$4.62, with returns of 24.5% over 7 days, 55.6% over 30 days, 61.0% year to date and 53.5% over 1 year, while the 3 year return sits at a 54.2% decline. Recent price moves have come as Rezolve AI continues to attract attention in the AI and software space, where investor interest can quickly...

If you are wondering whether Moelis at around US$77.75 is offering fair value or a stretched price, you are not alone. That is exactly what this article will unpack. The stock has recently posted returns of 4.6% over 7 days, 12.1% over 30 days, 9.2% year to date, 5.7% over 1 year, 99.0% over 3 years and 93.8% over 5 years, which naturally raises questions about where value now sits. Recent coverage of Moelis has focused on its position within the diversified financials space and ongoing...

Oscar Health (OSCR) is back in focus after the U.S. House of Representatives approved a bill to extend Affordable Care Act subsidies, a key support for insurers concentrated in the individual exchange market. See our latest analysis for Oscar Health. The policy news arrives after a mixed stretch for the stock, with a 10.88% 1 month share price return and a 16.37% year to date share price return set against a 10.16% 3 month share price decline. At the same time, the 3 year total shareholder...

Earlier this week, BMO Capital upgraded ManpowerGroup, citing expectations for better operating trends at the workforce solutions provider following its recent performance. The upgrade highlights how shifts in analyst confidence can influence investor focus on ManpowerGroup’s execution in a rapidly evolving labor market. Next, we’ll examine how BMO Capital’s improved view on ManpowerGroup’s operating trends may affect the company’s existing investment narrative. The best AI stocks today may...

In recent months, Brady Corporation reported solid quarterly results, with five-year compounded annual revenue growth of 7.5% and earnings per share increasing 15.7% annually. These figures highlight that Brady’s offerings continue to appeal to customers even as its core organic revenue growth slowed to 1.6% over the past two years. While strong long-term sales and earnings trends underscore the effectiveness of Brady’s product portfolio and execution, the recent slowdown in organic growth...

STAAR Surgical recently reshaped its board after shareholders rejected a proposed merger with Alcon, adding three investor-affiliated directors while CEO Stephen Farrell stepped down from the board but remains in the role until January 31, 2026. This shift hands greater influence to major shareholder Broadwood Partners and its allies, signaling potential changes in governance priorities and capital allocation for the standalone company. With Broadwood-backed directors now on the board, we’ll...

If you are wondering whether Easterly Government Properties is attractively priced or not, you are in the right place. This article is built around helping you make sense of what the current share price might imply. The stock last closed at US$22.87, with returns of 1.1% over the past week, 2.7% over the past month, a 7.3% gain year to date, and declines of 13.2% over 1 year, 24.4% over 3 years, and 43.5% over 5 years. This can signal shifting views on both its potential and its...

H.B. Fuller FY 2025 earnings snapshot H.B. Fuller (FUL) has wrapped up FY 2025 with fourth quarter revenue of US$894.8 million and basic EPS of US$0.55, setting the tone for a year where earnings momentum and margin progression were in focus for investors. The company has seen quarterly revenue move from US$917.9 million in Q3 2024 to the US$788.7 million to US$898.1 million range across the first three quarters of 2025, while basic EPS shifted from US$1.01 in Q3 2024 to US$0.24, US$0.77 and...

Lemonade recently reported past quarterly results showing improving profitability metrics, including a steadily declining gross loss ratio and positive adjusted free cash flow, alongside strong growth in in-force premiums. These efficiency gains suggest Lemonade’s AI-driven underwriting and claims systems are materially improving how much of each premium dollar the company keeps. We’ll now examine how Lemonade’s improving gross loss ratio reshapes its existing investment narrative and what...

If you are wondering whether Planet Labs PBC is still reasonably priced after its recent run, this article walks through what the current share price might be implying about the business. The stock closed at US$28.28, with returns of 26.0% over 7 days, 58.2% over 30 days, 38.6% year to date, and a very large gain over 1 year that is more than 7x. Recent coverage has focused on Planet Labs PBC's role in satellite powered Earth observation and how its data products are being used across areas...

In the past few days, Grabar Law Office began investigating Molina Healthcare over alleged failures to disclose key medical cost and guidance-related risks, including assumptions about cost trends, premium–cost alignment, and potential cuts to fiscal year 2025 guidance. This investigation raises fresh questions about how accurately Molina’s internal expectations around medical utilization and pricing were communicated to shareholders, and how resilient its business model is to those...

Krystal Biotech (KRYS) has drawn fresh attention after recent trading left the stock with a 1 day return of 3.35% and a past 3 months return of 48.25%, prompting investors to reassess its profile. See our latest analysis for Krystal Biotech. That move comes on top of a 13.3% 7 day share price return, an 18.2% 30 day share price return, and a 48.3% 90 day share price return. The 1 year total shareholder return of 94.7% and 3 year total shareholder return above 2.5x suggest strong momentum has...

In early January 2026, Hancock Whitney Corporation elevated long-time executive Emory Mayfield to Chief Banking Officer and hired Devon Bray as executive vice president and director of Business Banking and SBA, tasking them with overseeing core banking lines and sharpening the bank’s business banking and digital capabilities. These leadership changes arrive just ahead of Hancock Whitney’s upcoming quarterly earnings release, focusing investor attention on how a refreshed banking team may...

Mind Medicine (MindMed) (DFTX) is rebranding to Deinium Therapeutics and switching its Nasdaq ticker from MNMD to DFTX on January 15, 2026, drawing fresh attention to its psychiatry focused pipeline. See our latest analysis for Mind Medicine (MindMed). The rebrand to Deinium Therapeutics and new DFTX ticker come after a period of strong momentum, with a 30 day share price return of 25.45% and a 1 year total shareholder return of 136.25%, although the 5 year total shareholder return remains a...

If you are wondering whether Enphase Energy is a bargain or a value trap at its current price, the key is to understand what the recent numbers actually say about the stock. The share price closed at US$35.36, with returns of 11.0% over 30 days and 4.8% year to date, but also a 44.3% decline over 1 year and an 84.1% decline over 3 years. Recent news around Enphase has focused on the broader solar and clean energy sector, including investor debates about demand for residential solar equipment...

News (NWSA) is back in focus after agreeing to deploy Symbolic.ai’s publishing platform inside Dow Jones Newswires. The move highlights management’s push to weave artificial intelligence more deeply into its financial news operations. See our latest analysis for News. At a share price of US$26.70, News has seen a 3.1% 30 day share price return and a 46.5% three year total shareholder return. The 1 year total shareholder return of a 2.2% decline suggests momentum has cooled, even as management...

If you are wondering whether Albertsons Companies stock offers good value at today’s price, you are not alone. This article is built to help you frame that question clearly before you make any decisions. The share price closed at US$17.38 recently, with returns of 4.5% over the last 7 days, a 0.5% decline over 30 days, a 0.4% gain year to date, and an 11.4% decline over 1 year, while the 5 year return sits at 49.3%. These mixed returns have kept Albertsons on many watchlists, as investors...

If you have been wondering whether Omnicom Group's share price still reflects its underlying business, this article walks through what the current numbers actually say about value. The stock last closed at US$80.84, with returns of 2.6% over the past 7 days, 0.2% over the past 30 days, a 0.6% decline year to date and a 2.3% decline over the past year. This is set against gains of 8.8% over 3 years and 52.6% over 5 years. Recent coverage has focused on how global advertising and marketing...

If you are wondering whether Booking Holdings at around US$5,193 per share still offers value, you are not alone. Many investors are rechecking what a fair price looks like for this travel heavyweight. The stock is currently showing a 4.6% decline over 7 days, a 4.5% decline over 30 days, is down 2.4% year to date, yet is up 7.5% over 1 year and has a very large 3 year and 5 year return that can matter for how you think about risk and potential reward. Recent news coverage around Booking...

Why AIRO Group Holdings (AIRO) Is Back on Investors’ Radar Recent coverage around AIRO Group Holdings (AIRO) has zeroed in on its liquidity position and upcoming execution milestones, which together help explain the renewed interest you might be seeing in the stock. See our latest analysis for AIRO Group Holdings. After a sharp 71.65% 30 day share price return and a 42.86% year to date share price return, AIRO’s recent pullback, including a 24.57% 90 day share price decline and softer 1 day...

If you are wondering whether Northern Trust, at around US$147 a share, is offering fair value or a potential bargain, this article walks you through the numbers in plain English. The stock has returned 1.9% over the past week, 6.4% over the last 30 days, 5.6% year to date, 41.9% over 1 year, 79.4% over 3 years and 81.8% over 5 years, which raises fair questions about what is already priced in. Recent coverage of the US financial sector has kept established custody and asset servicing banks...